Pharma-Bio Serv, Inc. (PBSV) stock
PBSVOTCServices-Management Consulting ServicesFiscal year ends October 31
$0.48+0.08 (+20.00%)
Close on Oct 19, 2026Market cap $11.00MP/E 48.0Yield –
Earnings
Pharma-Bio Serv's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Jan 28, 2027
Q4 FY2026 · estimated, during market hours
Revenue, Q3 FY2026
$2.30M
+15.0% on a year earlier
EPS, Q3 FY2026
–
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of Pharma-Bio Serv's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Oct 31, 2026 | Jan 28, 2027Expected | – | – | – | – |
| Q3 FY2026ended Jul 31, 2026 | Sep 14, 2026during market hours | $2.30M | +15.0% | – | Release |
| Q2 FY2026ended Apr 30, 2026 | Jun 15, 2026during market hours | $2.70M | +12.5% | – | Release |
| Q1 FY2026ended Jan 31, 2026 | Mar 17, 2026during market hours | $2.30M | -8.0% | – | Release |
| Q4 FY2025ended Oct 31, 2025 | Jan 29, 2026during market hours | – | – | – | Release |
| Q3 FY2025ended Jul 31, 2025 | Sep 15, 2025during market hours | $2.00M | – | – | Release |
| Q2 FY2025ended Apr 30, 2025 | Jun 16, 2025during market hours | $2.40M | – | – | Release |
| Q1 FY2025ended Jan 31, 2025 | Mar 17, 2025during market hours | $2.50M | – | – | Release |
| Q4 FY2024ended Oct 31, 2024 | Jan 29, 2025during market hours | – | – | – | Release |
| Q3 FY2024ended Jul 31, 2024 | Sep 16, 2024during market hours | – | – | – | Release |
| Q2 FY2024ended Apr 30, 2024 | Jun 14, 2024during market hours | – | – | – | Release |
| Q1 FY2024ended Jan 31, 2024 | Mar 18, 2024during market hours | – | – | – | Release |
| Q4 FY2023ended Oct 31, 2023 | Jan 30, 2024during market hours | – | – | – | Release |
| Q3 FY2023ended Jul 31, 2023 | Sep 14, 2023during market hours | – | – | – | Release |
| Q2 FY2023ended Apr 30, 2023 | Jun 14, 2023during market hours | – | – | – | Release |
| Q1 FY2023ended Jan 31, 2023 | Mar 17, 2023during market hours | – | – | – | Release |
| Q4 FY2022ended Oct 31, 2022 | Jan 30, 2023during market hours | – | – | – | Release |
| Q1 FY2022ended Jul 31, 2022 | Sep 14, 2022during market hours | – | – | – | Release |
| Q2 FY2022ended Apr 30, 2022 | Jun 14, 2022during market hours | – | – | – | Release |
| Q4 FY2021ended Oct 31, 2021 | Feb 14, 2022before the open | – | – | – | Release |
| Q3 FY2021ended Jul 31, 2021 | Sep 14, 2021during market hours | – | – | – | Filing |
| Q2 FY2021ended Apr 30, 2021 | Jun 14, 2021during market hours | – | – | – | Filing |
| Q1 FY2021ended Jan 31, 2021 | Mar 17, 2021during market hours | – | – | – | Filing |
| Q2 FY2020ended Apr 30, 2020 | Jun 15, 2020during market hours | – | – | – | Filing |
| Q1 FY2020ended Jan 31, 2020 | Mar 16, 2020during market hours | – | – | – | Filing |
| Q4 FY2019ended Oct 31, 2019 | Jan 29, 2020during market hours | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Pharma-Bio Serv has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Pharma-Bio Serv puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Pharma-Bio Serv filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- News
- Results
- Results
- Results
- Results
- News
- Results
See a number that looks wrong?